tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

KALA Stock Latest News

Kala Bio Advances PCED Treatment Amid Financial Update
Company AnnouncementsKala Bio Advances PCED Treatment Amid Financial Update
1M ago
KALA
Kala Pharmaceuticals reports Q3 EPS ($1.93) vs ($3.41) last year
PremiumThe Fly
Kala Pharmaceuticals reports Q3 EPS ($1.93) vs ($3.41) last year
1M ago
KALA
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns
PremiumCompany Announcements
Kala Pharmaceuticals Board Member Mark Blumenkranz Resigns
3M ago
8K
KALA
Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
PremiumThe Fly
Oppenheimer ‘encouraged’ by Kala Pharmaceuticals trial progress
4M ago
KALA
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $15 from $18 at H.C. Wainwright
4M ago
KALA
Kala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
PremiumThe FlyKala Pharmaceuticals reports Q2 EPS ($3.16) vs ($4.36) last year
4M ago
KALA
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
Premium
The Fly
Kala Pharmaceuticals files to sell 3.52M shares of common stock for holders
5M ago
KALA
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
Premium
The Fly
Kala Pharmaceuticals to sell 1.197M shares at $5.85 in private placement
6M ago
KALA
Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $18 from $21 at H.C. Wainwright
7M ago
KALA
Kala Pharmaceuticals reports Q1 EPS ($4.20), consensus ($(2.89)
PremiumThe Fly
Kala Pharmaceuticals reports Q1 EPS ($4.20), consensus ($(2.89)
7M ago
KALA
Kala Pharmaceuticals price target lowered to $21 from $22 at H.C. Wainwright
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $21 from $22 at H.C. Wainwright
9M ago
KALA
KALA Earnings this Week: How Will it Perform?
PremiumPre-Earnings
KALA Earnings this Week: How Will it Perform?
9M ago
KALA
KALA Pharmaceuticals Spotlights Ophthalmology Advances
PremiumCompany AnnouncementsKALA Pharmaceuticals Spotlights Ophthalmology Advances
10M ago
8K
KALA
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
AKRO
HOTH
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1y ago
AKRO
ATHE
Kala Pharmaceuticals price target lowered to $22 from $24 at H.C. Wainwright
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $22 from $24 at H.C. Wainwright
1y ago
KALA
Kala Pharmaceuticals price target lowered to $22 from $39 at Wedbush
PremiumThe Fly
Kala Pharmaceuticals price target lowered to $22 from $39 at Wedbush
1y ago
KALA
Kala Pharmaceuticals reports Q2 EPS ($3.41), consensus ($2.15)
PremiumThe Fly
Kala Pharmaceuticals reports Q2 EPS ($3.41), consensus ($2.15)
1y ago
KALA
Kala Pharmaceuticals reports Q2 EPS ($4.36), consensus ($3.19)
PremiumThe Fly
Kala Pharmaceuticals reports Q2 EPS ($4.36), consensus ($3.19)
1y ago
KALA
Kala Pharmaceuticals to change name to KALA BIO
PremiumThe FlyKala Pharmaceuticals to change name to KALA BIO
1y ago
KALA
KALA Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
KALA Upcoming Earnings Report: What to Expect?
2y ago
KALA
Kala Pharmaceuticals’ Combangio awarded $15M from CIRM
Premium
The Fly
Kala Pharmaceuticals’ Combangio awarded $15M from CIRM
2y ago
KALA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >